This placebo-controlled, double-blind, randomized clinical trial investigated the efficacy of single-dose psilocybin-assisted therapy for treating major depressive disorder (MDD) in 59 participants. The results demonstrated... Continue reading
Monthly Archives: December 2022
This study investigates the efficacy of single-dose psilocybin-assisted therapy for patients with major depressive disorder (MDD) through a double-blind, randomized, placebo-controlled clinical trial. The findings... Continue reading
This paper explores the attitudes and openness of psychotherapists towards the integration of psilocybin-assisted therapy (PAT) into mental health treatment, revealing that the majority (71%)... Continue reading
A recent double-blind, randomized, and placebo-controlled study has demonstrated that psilocybin-assisted therapy can significantly improve the psycho-social-spiritual well-being of cancer patients. The research found that... Continue reading
An international web-based survey examining the risks and benefits of psilocybin use among individuals with bipolar disorder found that while some participants reported potential therapeutic... Continue reading
An international web-based survey examining the risks and benefits of psilocybin use among individuals with bipolar disorder found that while some participants reported potential therapeutic... Continue reading